Get started
Author

Fabian Kortum

ORCID: 0000-0003-1387-1350
Observed ORCID: 0000-0003-1387-1350
OpenAlex ID: A5084232882
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
2022 · Sven Göbel, Fabian Kortum, et al. · Applied Microbiology and Biotechnology · 21
PDF
Syncytial death mediated by oncolytic rVSV-NDV dynamically activates immunogenic apoptosis and necroptosis in human lung cancer cells
2025 · Fabian Kortum, Nina Hartmann, et al. · Molecular Therapy Oncology · 4
937 In situ TCE: targeting solid tumor antigens previously inaccessible to T Cell engager therapy
2026 · Duong H Nguyen, Yunyi Kang, et al. · Journal for ImmunoTherapy of Cancer
PDF
829 RedTail/CLD-401: a systemically delivered oncolytic vaccinia platform enabling in situ IL-15 superagonist expression for solid tumor immunotherapy
2026 · Yunyi Kang, Duong H Nguyen, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract B018: CLD-501, an In Situ T Cell Engager Targeting TROP2: Reprogramming Solid Tumors to Generate Their Own Immunotherapy
2026 · Duong Hoang. Nguyen, Yunyi Kang, et al. · Clinical Cancer Research
Abstract B017: CLD-401, a Systemic Gene Medicine for In Situ IL-15 Superagonist Delivery: Driving NK and γδ T Cell-Mediated Tumor Killing
2026 · Yunyi Kang, Duong H. Nguyen, et al. · Clinical Cancer Research
CLD-401: A next-generation systemic gene therapy for tumor-localized expression of IL-15 superagonist.
2026 · Yunyi Kang, Duong Hoang Nguyen, et al. · Journal of Clinical Oncology
PDF
RedTail: A next-generation systemic platform for tumor-localized expression of BiTEs and immune activation.
2026 · Duong Hoang Nguyen, Yunyi Kang, et al. · Journal of Clinical Oncology
Abstract 266: Redtail: A dual-programmable virotherapy platform for systemic tumor targeting and localized gene delivery.
2026 · Yunyi Kang, Duong H. Nguyen, et al. · Cancer Research
Abstract 4310: CLD-401, an IL-15 superagonist gene medicine via redtail virotherapy, achieves sustained tumor eradication
2026 · Duong H. Nguyen, Yunyi Kang, et al. · Cancer Research
Abstract LB-C005: RedTail: A next-generation systemic platform for tumor-specific delivery of bites and immune activation
2026 · Duong H. Nguyen, Yunyi Kang, et al. · Cancer Immunology Research
1175 In situ tumor delivery of IL-15 superagonist via RedTail gene therapy achieves durable tumor clearance
2025 · Yunyi Kang, Duong Nguyen, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 12
Citation count: 25
H-index: 2
I10-index: 1
Year
Topic
Type